Metabolic Disease Unit, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel-Hashomer, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Am J Med Genet A. 2020 May;182(5):987-993. doi: 10.1002/ajmg.a.61509. Epub 2020 Mar 7.
The genetic basis of congenital heart malformations associated with disruption of left-right (L-R) asymmetry is broad and heterogenous, with variants in over 25 genes implicated thus far. Of these, deleterious variants in the Growth/Differentiation Factor 1 (GDF1) gene have been shown to cause heterotaxy with varied complex heart malformations of left-right patterning, in 23 individuals reported to date, either in monoallelic or biallelic state. We report three unrelated individuals exhibiting right isomerism with congenital heart defects, each originating from a consanguineous kindred of Arab-Muslim descent. Using whole exome sequencing, a shared novel homozygous truncating c.608G > A (p.W203*) variant in the GDF1 gene was revealed as the molecular basis of their disease. Subsequently, targeted sequencing of this variant showed full segregation with the disease in these families, with a total of over 15 reportedly affected individuals, enabling genetic counseling, prenatal diagnosis, and planning of future pregnancies. Our findings further confirm the association of biallelic GDF1 variants, heterotaxy and congenital heart defects of left-right patterning, and expand the previously described phenotypic spectrum and mutational profile. Moreover, we suggest targeted screening for the p.W203* variant in relevant clinical circumstances.
与左右(L-R)不对称破坏相关的先天性心脏畸形的遗传基础广泛且具有异质性,迄今为止已有超过 25 个基因的变异与此相关。在这些基因中,生长/分化因子 1(GDF1)基因中的有害变异已被证明可导致异构性,并伴有不同的复杂心脏畸形左右模式,迄今为止在 23 名报告的个体中,无论是单等位基因还是双等位基因状态。我们报告了三个无关个体,他们都存在先天性心脏缺陷的右异构性,每个个体都来自阿拉伯-穆斯林血统的近亲。使用全外显子组测序,揭示了 GDF1 基因中一个共享的新型纯合截断 c.608G > A(p.W203*)变异,这是他们疾病的分子基础。随后,对该变体的靶向测序显示,该变体在这些家族中与疾病完全分离,共有超过 15 名报告的受影响个体,从而能够进行遗传咨询、产前诊断和未来妊娠计划。我们的发现进一步证实了双等位基因 GDF1 变异、异构性和左右模式的先天性心脏缺陷之间的关联,并扩展了先前描述的表型谱和突变谱。此外,我们建议在相关临床情况下针对 p.W203* 变体进行靶向筛查。